Shenzhen Noposion Agrochemicals Co.,Ltd

SZSE:002215.SZ

7.44 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 4,133.444,265.1694,500.5724,131.4254,058.3954,005.4442,821.5751,962.9262,209.7452,202.7241,735.5011,597.5161,554.9431,455.9381,308.2341,065.917722.376312.471158.93893.868
Cost of Revenue 2,906.293,108.8683,289.1853,086.9082,997.482,835.2661,830.6561,239.861,226.2781,345.6961,023.942937.744895.225848.448748.797670.717476.384216.578124.2867.877
Gross Profit 1,227.151,156.3011,211.3871,044.5171,060.9141,170.178990.919723.067983.467857.028711.559659.772659.718607.49559.437395.2245.99295.89334.65825.991
Gross Profit Ratio 0.2970.2710.2690.2530.2610.2920.3510.3680.4450.3890.410.4130.4240.4170.4280.3710.3410.3070.2180.277
Reseach & Development Expenses 118.896125.621107.37799.03192.97399.489.57497.180.59378.04265.65459.900000000
General & Administrative Expenses 109.41691.112112.825122.882120.465121.928106.459316.4873.92259.60155.84653.884208.191194.856169.682114.37767.35727.75212.0519.25
Selling & Marketing Expenses 422.923409.113454.013401.897466.754474.566436.927591.915491.709375.882332.726353.256363.269299.014231.801165.71493.93930.5499.8736.239
SG&A 532.339500.226566.839524.779587.219596.494543.385908.395565.631435.483388.572407.141571.459493.87401.483280.091161.29658.30121.92415.49
Other Expenses -3,909.243122.921113.42115.70785.617-0.0642.51916.2076.6621.74212.01644.28918.36410.25212.4247.1880.3830.046-0.251.019
Operating Expenses 3,909.243748.768787.636739.516765.809794.034722.2091,114.932763.615599.443544.453561.641577.452498.358403.963282.056162.17658.56222.0115.559
Operating Income 224.197497.275477.307340.2355.232385.754351.064-301.373252.216217.075183.547111.70281.354118.79157.145106.29680.18236.35612.54410.074
Operating Income Ratio 0.0540.1170.1060.0820.0880.0960.124-0.1540.1140.0990.1060.070.0520.0820.120.10.1110.1160.0790.107
Total Other Income Expenses Net 1.406-152.613-134.299-146.174-91.7989.54784.873106.14638.898-18.96927.64251.16615.74919.59713.869-2.349-3.293-0.929-0.3540.428
Income Before Tax 225.603344.662343.009194.026263.434385.69353.583-285.72258.751238.617194.747149.29698.014128.729169.343110.79580.52336.40212.29410.861
Income Before Tax Ratio 0.0550.0810.0760.0470.0650.0960.125-0.1460.1170.1080.1120.0930.0630.0880.1290.1040.1110.1160.0770.116
Income Tax Expense -7.6817.48545.74419.34612.44643.07233.159-9.30325.52744.6516.68117.44715.81218.39326.67118.22711.3894.7491.2280.966
Net Income 235.627328.438305.334166.911236.009329.166308.506-276.247230.863194.48180.017129.37681.343108.804137.79791.71663.47729.90410.7639.895
Net Income Ratio 0.0570.0770.0680.040.0580.0820.109-0.1410.1040.0880.1040.0810.0520.0750.1050.0860.0880.0960.0680.105
EPS 0.240.330.340.190.260.360.34-0.30.250.220.20.140.0910.120.170.120.10.0580.0220.36
EPS Diluted 0.240.330.330.180.260.360.34-0.30.250.220.20.140.0910.120.170.120.10.0580.0220.36
EBITDA 741.123681.187633.708440.719450.123558.098470.627-201.859312.848285.706255.294223.106168.39169.521188.404130.70191.03940.80714.01512.369
EBITDA Ratio 0.1790.160.1410.1070.1110.1390.167-0.1030.1420.130.1470.140.1080.1160.1440.1230.1260.1310.0880.132